Liver Transplanted Patients Completed Phase 3 Trials for Tacrolimus (DB00864)

Also known as: Liver Transplant Recipients / Liver Transplant Recipient

IndicationStatusPhase
DBCOND0066753 (Liver Transplanted Patients)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01150097Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant RecipientsTreatment